EUVIMEDEUVIMED entdecken
Open Access

Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls

Frances Cheung iD, Katina C Calakos, Ralitza Gueorguieva iD, Ansel T Hillmer, Kelly P Cosgrove, Yasmin Zakiniaeiz iD

Nicotine and Tobacco Research · 2024

DOI: 10.1093/ntr/ntae031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2024. Verfasst von Frances Cheung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yale College, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Receptors, Dopamine D2, Receptors, Dopamine D3, Cognition, Dopamine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In the dopamine system, the mesolimbic pathway, including the dorsal striatum, underlies the reinforcing properties of tobacco smoking, and the mesocortical pathway, including the dorsolateral prefrontal cortex (dlPFC), is critical for cognitive functioning. Dysregulated dopamine signaling has been linked to drug-seeking behaviors and cognitive deficits. The dorsal striatum and dlPFC are structurally and functionally connected and are key regions for cognitive functioning. We recently showed that people who smoke have lower dlPFC dopamine (D2/3R) receptor availability than people who do not, which is related to poorer cognitive function. Aims and Methods The goal of this study was to examine the same brain-behavior relationship in the dorsal striatum. Twenty-nine (18 males) recently abstinent people who smoke and 29 sex-matched healthy controls participated in 2 same-day [11C]-(+)-PHNO positron emission tomography scans before and after amphetamine administration to provoke dopamine release. D2/3R availability (binding potential; BPND) and amphetamine-induced dopamine release (%ΔBPND) were calculated. Cognition (verbal learning and memory) was assessed with the CogState computerized battery.

Results

There were no group differences in baseline BPND. People who smoke have a smaller magnitude %ΔBPND in dorsal putamen than healthy controls (p = .022). People who smoke perform worse on immediate (p = .035) and delayed (p = .011) recall than healthy controls. In all people, lower dorsal putamen BPND was associated with worse immediate (p = .006) and delayed recall (p = .049), and lower %ΔBPND was related to worse delayed recall (p = .022).

Conclusions

Lower dorsal putamen D2/3R availability and function are associated with disruptions in cognitive function that may underlie difficulty with resisting smoking.

Implications

This study directly relates dopamine imaging outcomes in the dorsal striatum to cognitive function in recently abstinent people who smoke cigarettes and healthy controls. The current work included a well-characterized subject sample in terms of demographics, smoking characteristics, and a validated neurocognitive test of verbal learning and memory. The findings of this study extend previous literature relating dopamine imaging outcomes to cognition in recently abstinent people who smoke and people who do not smoke, expanding our understanding of brain-behavior relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Dopamine D2Receptors, Dopamine D3CognitionDopaminePositron-Emission TomographyPutamenAmphetamineHumansMaleAdultFemaleCase-Control StudiesYoung AdultMiddle AgedSmokingSmoking Cessation

Substanzen

Receptors, Dopamine D2Receptors, Dopamine D3DopamineAmphetamineDRD2 protein, humanDRD3 protein, human

Autor:innen und Institutionen

  • Yale College, Yale University, New Haven, CT, USA.
  • Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
  • Department of Biostatistics, School of Public Health, Yale University, New Haven, CT, USA.
  • Yale Positron Emission Tomography (PET) Center, School of Medicine, Yale University, New Haven, CT, USA.
  • Department of Radiology and Biomedical Imaging, School of Medicine, Yale University, New Haven, CT, USA.

ORCID-Profile: Frances Cheung, Ralitza Gueorguieva, Yasmin Zakiniaeiz

Förderung

  • NCATS NIH HHS
  • NIDA NIH HHS
  • NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Zitieren

APA

Cheung, F., Calakos, K. C., Gueorguieva, R., Hillmer, A. T., Cosgrove, K. P., & Zakiniaeiz, Y. (2024). Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae031

Vancouver

Cheung F, Calakos KC, Gueorguieva R, Hillmer AT, Cosgrove KP, Zakiniaeiz Y. Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls. Nicotine and Tobacco Research. 2024. doi:10.1093/ntr/ntae031

BibTeX
@article{Cheung2024,
  author = {Cheung, Frances and Calakos, Katina C and Gueorguieva, Ralitza and Hillmer, Ansel T and Cosgrove, Kelly P and Zakiniaeiz, Yasmin},
  title = {Lower Dorsal Putamen D2/3 Receptor Availability and Amphetamine-Induced Dopamine Release are Related to Poorer Cognitive Function in Recently Abstinent People Who Smoke and Healthy Controls},
  journal = {Nicotine and Tobacco Research},
  year = {2024},
  doi = {10.1093/ntr/ntae031}
}
Kostenlos starten →